Minimal residual disease and relapse surveillance in osteosarcoma: an action-linked framework integrating liquid biopsy and imaging biomarkers

Osteosarcoma relapse surveillance remains dominated by scheduled imaging because salvage treatment depends on anatomical confirmation of pulmonary, local or extrapulmonary recurrence. However, radiological recurrence may occur after a biologically active phase in which residual viable disease or mic